atomoxetine
Showing 1 - 25 of 112
Obstructive Sleep Apnea Trial in Boston (Atomoxetine, Oxybutynin)
Not yet recruiting
- Obstructive Sleep Apnea
- Atomoxetine
- Oxybutynin
-
Boston, MassachusettsBrigham and Women's Hospital
Sep 19, 2022
ADHD, Dyslexia Trial in New Haven (Atomoxetine, Placebo)
Completed
- Attention Deficit Hyperactivity Disorder
- Dyslexia
- Atomoxetine
- Placebo
-
New Haven, ConnecticutYale University School of Medicine
Oct 9, 2022
Tourette Syndrome Trial in Poitiers (Atomoxetine)
Recruiting
- Tourette Syndrome
- Atomoxetine
-
Poitiers, FranceCHU Poitiers
Jun 9, 2022
Bariatric Surgery and Pharmacokinetics of Atomoxetine
Recruiting
- Obesity, Morbid
- Atomoxetine
-
Trondheim, NorwaySt. Olavs University Hospital
Mar 21, 2022
Obstructive Sleep Apnea, Hypertension Trial in Towson (AD113, Atomoxetine)
Recruiting
- Obstructive Sleep Apnea
- Hypertension
- AD113
- Atomoxetine
-
Towson, MarylandPCCAB
Jun 9, 2022
Cancer, Cognitive Late Effects Trial in Philadelphia (Atomoxetine)
Withdrawn
- Cancer
- Cognitive Late Effects
- Atomoxetine
-
Philadelphia, PennsylvaniaTemple University
Mar 30, 2022
Parkinson's Disease, Idiopathic Trial in Cleveland (Methylphenidate, Physical Therapy, Atomoxetine)
Recruiting
- Parkinson's Disease, Idiopathic
- Methylphenidate
- +2 more
-
Cleveland, OhioCleveland Clinic
Feb 15, 2022
Tachycardia, Chronic Orthostatic Intolerance Trial in Nashville (drug, other, dietary supplement, radiation, procedure, device)
Active, not recruiting
- Tachycardia
- Chronic Orthostatic Intolerance
- Acetazolamide
- +22 more
-
Nashville, TennesseeVanderbilt University Autonomic Dysfunction Center
Sep 12, 2022
Neurogenic Orthostatic Hypotension Trial in New York, Nashville (Atomoxetine, Placebo)
Active, not recruiting
- Neurogenic Orthostatic Hypotension
- Atomoxetine
- Placebo
-
New York, New York
- +1 more
Aug 22, 2022
Orthostatic Intolerance Trial in Nashville (Atomoxetine, Placebo)
Completed
- Orthostatic Intolerance
- Atomoxetine
- Placebo
-
Nashville, TennesseeCyndya Shibao
Mar 1, 2022
ADHD, ADHD Trial in New York (Methylphenidate, Atomoxetine)
Recruiting
- ADHD
- Attention Deficit Hyperactivity Disorder
- Methylphenidate
- Atomoxetine
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Apr 5, 2022
Sleep Apnea Trial in Boston (Atomoxetine, Oxybutynin, Placebo)
Recruiting
- Sleep Apnea
- Atomoxetine
- +2 more
-
Boston, MassachusettsBrigham and Women's Hospital
Mar 25, 2021
Cognition in Schizophrenia Trial in Dallas (Atomoxetine, Placebo)
Completed
- Cognition in Schizophrenia
- Atomoxetine
- Placebo
-
Dallas, TexasThe University of Texas Southwestern Medical Center
Sep 24, 2020
Vasovagal Syncope Trial in Calgary (Atomoxetine, Placebo)
Completed
- Vasovagal Syncope
- Atomoxetine
- Placebo
-
Calgary, Alberta, CanadaUniversity of Calgary
Apr 20, 2020
Memory Disorders, Multiple Sclerosis Trial in New York (Atomoxetine, Placebo)
Completed
- Memory Disorders
- Multiple Sclerosis
- Atomoxetine
- Placebo
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Feb 26, 2020
ADHD Trial in Buffalo (atomoxetine, Behavior Modification Therapy)
Completed
- Attention Deficit Hyperactivity Disorder
- atomoxetine
- Behavior Modification Therapy
-
Buffalo, New YorkCennter for Children and Families
Oct 16, 2020
Suicidality, Psychosis or Substance Abuse With Methylphenidate,
Completed
- Attention Deficit Disorder With Hyperactivity
- Methylphenidate
- +4 more
-
Titusville, New JerseyJanssen Investigative Site
Nov 7, 2019
Type 1 Diabetes Trial in Baltimore (Atomoxetine, Placebo)
Completed
- Type 1 Diabetes
- Atomoxetine
- Placebo
-
Baltimore, MarylandUniverisity of Maryland, Baltimore
Sep 10, 2019
Schizophrenia Trial in Baltimore, Catonsville (Atomoxetine)
Completed
- Schizophrenia
- Atomoxetine
-
Baltimore, Maryland
- +1 more
Aug 15, 2019
Adult ADHD Trial in United States (OPC-64005, Atomoxetine, Placebo)
Completed
- Adult Attention Deficit Hyperactivity Disorder
- OPC-64005
- +2 more
-
Beverly Hills, California
- +25 more
Sep 30, 2021
Mild Cognitive Impairment Trial in Atlanta (Atomoxetine, Placebo)
Completed
- Mild Cognitive Impairment
- Atomoxetine
- Placebo
-
Atlanta, GeorgiaEmory University School of Medicine
Jul 12, 2019
ADHD Trial in Tanta (Atomoxetine, Coenzyme Q)
Recruiting
- ADHD
- Atomoxetine
- Coenzyme Q
-
Tanta, EgyptSherief Abd-Elsalam
Dec 29, 2019
ADHD Trial in Taipei (Methylphenidate, Atomoxetine)
Unknown status
- Attention Deficit Hyperactivity Disorder
- Methylphenidate
- Atomoxetine
-
Taipei, TaiwanNational Taiwan University Hospital
May 2, 2019